» Articles » PMID: 26658454

The Experimental Power of FR900359 to Study Gq-regulated Biological Processes

Abstract

Despite the discovery of heterotrimeric αβγ G proteins ∼25 years ago, their selective perturbation by cell-permeable inhibitors remains a fundamental challenge. Here we report that the plant-derived depsipeptide FR900359 (FR) is ideally suited to this task. Using a multifaceted approach we systematically characterize FR as a selective inhibitor of Gq/11/14 over all other mammalian Gα isoforms and elaborate its molecular mechanism of action. We also use FR to investigate whether inhibition of Gq proteins is an effective post-receptor strategy to target oncogenic signalling, using melanoma as a model system. FR suppresses many of the hallmark features that are central to the malignancy of melanoma cells, thereby providing new opportunities for therapeutic intervention. Just as pertussis toxin is used extensively to probe and inhibit the signalling of Gi/o proteins, we anticipate that FR will at least be its equivalent for investigating the biological relevance of Gq.

Citing Articles

Identification of CKAP2 as a Potential Target for Prevention of Gastric Cancer Progression: A Multi-Omics Study.

Liu X, Zhang W, Wang H, Yang W Int J Mol Sci. 2025; 26(4).

PMID: 40004022 PMC: 11855583. DOI: 10.3390/ijms26041557.


Essential strategies for the detection of constitutive and ligand-dependent Gi-directed activity of 7TM receptors using bioluminescence resonance energy transfer.

Endzhievskaya S, Chahal K, Resnick J, Khare E, Roy S, Handel T bioRxiv. 2024; .

PMID: 39713355 PMC: 11661105. DOI: 10.1101/2024.12.04.626681.


QSP modeling of a transiently inactivating antibody-drug conjugate highlights benefit of short antibody half life.

Khera E, Dharmarajan L, Hainzl D, Engelhardt V, Vostiarova H, Davis J J Pharmacokinet Pharmacodyn. 2024; 52(1):7.

PMID: 39690276 PMC: 11652588. DOI: 10.1007/s10928-024-09956-1.


Smart control lipid-based nanocarriers for fine-tuning gut hormone secretion.

Xu Y, Michalowski C, Koehler J, Darwish T, Guccio N, Alcaino C Sci Adv. 2024; 10(50):eadq9909.

PMID: 39671480 PMC: 11641013. DOI: 10.1126/sciadv.adq9909.


Syndecans modulate ghrelin receptor signaling.

Prins K, Mutsters N, Volker F, Huisman M, Mies R, Delhanty P J Mol Endocrinol. 2024; 74(1.

PMID: 39565158 PMC: 11729051. DOI: 10.1530/JME-24-0070.


References
1.
Hudson B, Shimpukade B, MacKenzie A, Butcher A, Pediani J, Christiansen E . The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. Mol Pharmacol. 2013; 84(5):710-25. PMC: 3807074. DOI: 10.1124/mol.113.087783. View

2.
Jacobsen S, Norskov-Lauritsen L, Thomsen A, Smajilovic S, Wellendorph P, Larsson N . Delineation of the GPRC6A receptor signaling pathways using a mammalian cell line stably expressing the receptor. J Pharmacol Exp Ther. 2013; 347(2):298-309. PMC: 11047948. DOI: 10.1124/jpet.113.206276. View

3.
Hennen S, Wang H, Peters L, Merten N, Simon K, Spinrath A . Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist. Sci Signal. 2013; 6(298):ra93. PMC: 4114018. DOI: 10.1126/scisignal.2004350. View

4.
Ran F, Hsu P, Wright J, Agarwala V, Scott D, Zhang F . Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013; 8(11):2281-2308. PMC: 3969860. DOI: 10.1038/nprot.2013.143. View

5.
Alexander N, Preininger A, Kaya A, Stein R, Hamm H, Meiler J . Energetic analysis of the rhodopsin-G-protein complex links the α5 helix to GDP release. Nat Struct Mol Biol. 2013; 21(1):56-63. PMC: 3947367. DOI: 10.1038/nsmb.2705. View